Production (Stage)
Cartesian Therapeutics, Inc.
RNAC
$10.32
-$0.10-0.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M |
| Total Depreciation and Amortization | 1.16M | 486.00K | 286.00K | 196.00K | 183.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 528.00K | -4.08M | 11.78M | 3.60M | 47.09M |
| Change in Net Operating Assets | -7.08M | 6.85M | 25.81M | -32.08M | -6.37M |
| Cash from Operations | -23.11M | -7.00M | 13.69M | -14.45M | -15.92M |
| Capital Expenditure | -1.08M | -705.00K | -6.20M | -1.59M | -602.00K |
| Sale of Property, Plant, and Equipment | -- | 351.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.08M | -354.00K | -6.20M | -1.59M | -602.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 183.00K | 849.00K | 124.49M | 120.00K | 3.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 40.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.21M | -66.00K | -- | -- | -- |
| Cash from Financing | -8.03M | 783.00K | 124.49M | 120.00K | 43.03M |
| Foreign Exchange rate Adjustments | 32.00K | -15.00K | -15.00K | 14.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.18M | -6.59M | 131.97M | -15.90M | 26.51M |